CD4 and myeloid sarcoma: Stimulated CD4 cells showed significantly lower levels of TSPAN32 than the unstimulated counterparts; in addition, comparison between the CD4 T from healthy controls and MS patients showed that, upon stimulation, CD4 T cells from MS patients showed significantly lower transcriptional levels of TSPAN32.